You are here: Home » News-CM » Companies » News
Business Standard

Shilpa Medicare update on USFDA inspection of facility at Jadcherla, Telangana

Capital Market 

Receives 10 observations under Form 483

has received 483 Observations from the United States Food & Drug Administration (USFDA) in relation to SEZ Formulation Facilities situated at Jadcherla, (near Hyderabad) as under;

a) Total 10 observations were cited during the close up meeting.
b) 7 observations are improvement in procedures and practices.
c) 3 observations are related to setting of analytical specifications, test procedures and method validation.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, December 06 2017. 09:57 IST